Paraza Pharma appoints Mr. Aazer Siddiqui
Paraza Pharma appoints Mr. Aazer Siddiqui as Chief Strategy & Corporate Development Officer. Aazer will be part of the Executive Management Team of Paraza and will be involved in the management of the overall strategic planning process of the company. He will also help develop strategies to incorporate emerging technologies within the Paraza portfolio.
Paraza Lecture Series – Professor André B. Charette, Université de Montréal
We are honored to welcome Professor André B. Charette from the Université de Montréal at Paraza Pharma on January 24th, 2023 as part of the Paraza Lecture Series.
“Journée Carrière” at the Université de Montréal
On January 17, 2023 – Paraza Pharma is pleased to announce that we are sponsoring and will be participating in the “Journée Carrière” at the Université de Montréal.
Paraza Lecture Series
We are honored to welcome Professor Bertand Routy from the CHUM, the University of Montreal Hospital Center, at Paraza Pharma.
BIOQuebec’s Café Croissant Event
Paraza Pharma participated in BIOQuebec’s Café Croissant Event
Paraza Lecture Series
We are honored to welcome Professor Mark Lautens from the University of Toronto at Paraza Pharma.
QOMSBOC 2022
Paraza Pharma is a proud sponsor of QOMSBOC 2022, which will be held at McMaster University, from October 14-16, 2022.
Paraza Pharma Inc. is pleased to announce a recent joint publication
Paraza Pharma Inc. is pleased to announce a recent joint publication that was coauthored with Repare Therapeutics.
Paraza Pharma appoints Dr. Sultan Ahmad
Paraza Pharma appoints Dr. Sultan Ahmad as Chief Business Officer.
Paraza Pharma is ISO 27001:2013 Certified
We are proud to announce that Paraza Pharma, Inc. has recently achieved ISO 27001:2013 (ISO 27001) certification, one of the most globally recognized information security standards.
ISO 27001 is the international standard that sets out the specification for an Information Security Management System (ISMS).